REG - FIL Limited Covidien plc Medtronic, Inc. - Form 8.3 - MEDTRONIC INC <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 7894TFIL Limited08 October 2014FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE1. KEY INFORMATION
Name of person dealing (Note 1)
FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
MEDTRONIC INC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
07-October-14
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities
25,656,542 2.61
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
3,500 0.00
Total
25,656,542 2.61
3,500 0.00
(b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(63) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
3. DEALINGS(Note 4)
Purchases and sales
Purchase/sale
Number of securities
Price per unit
Sale
92,674
64.1903 USD/ Share
Buy
29,900
64.2457 USD/ Share
Buy
110,700
64.0200 USD/ Share
Buy
40,178
64.1362 USD/ Share
Buy
8,852
64.1027 USD/ Share
Buy
1,400
64.0450 USD/ Share
Buy
4,550
64.1127 USD/ Share
Buy
2,208
64.1243 USD/ Share
Buy
12,705
64.0799 USD/ Share
Buy
1,200
64.0503 USD/ Share
Buy
1,600
64.2694 USD/ Share
Buy
5,200
64.1925 USD/ Share
Buy
128,463
64.1311 USD/ Share
Buy
129,113
64.0356 USD/ Share
Buy
69,116
64.0246 USD/ Share
Buy
6,400
64.0172 USD/ Share
Buy
54,690
64.0288 USD/ Share
Buy
42,872
64.0384 USD/ Share
Buy
700
64.1793 USD/ Share
Buy
14,000
64.0444 USD/ Share
Buy
562
63.9800 USD/ Share
Buy
445
64.0350 USD/ Share
Buy
300
64.0900 USD/ Share
Buy
50,000
64.3200 USD/ Share
Buy
81,596
64.3612 USD/ Share
Sale
1,700
64.1738 USD/ Share
Buy
282
64.1700 USD/ Share
Buy
66,568
64.0334 USD/ Share
Sale
200
64.3400 USD/ Share
Buy
6
63.9400 USD/ Share
Buy
11
65.0200 USD/ Share
Buy
58
65.0900 USD/ Share
Buy
96
65.2300 USD/ Share
Buy
29
65.0300 USD/ Share
Sale
75
65.0200 USD/ Share
Sale
1
65.0100 USD/ Share
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price
Type, e.g. American, European etc.
Expiry
date
Option money
paid/received per unit (Note 5)
(ii) Exercising
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached?(Note 9)YES
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as
appropriate)
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Call Option
Written
500
USD 70.00
American
22 November 2014
Call Option
Written
1,000
USD 70.00
American
17 January 2015
Call Option
Written
1,000
USD 67.50
American
22 November 2014
Call Option
Written
1,000
USD 65.00
American
18 October 2014
Date of disclosure
08 October 2014
Contact name
Nevelina Rousseva-Gasnier
Telephone number
+44 (0)1737 837216
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEXVLFBZBFBFBX
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement